MedTrace Logo

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

NCT04605952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2020-10-28

No results posted yet for this study

Summary

As a serosurveillance measure asymptomatic employees of an industrial workforce Jamshedpur (India) were tested for COVID-19 IgG antibodies. Of the tested employees who were positive for COVID-19 IgG antibodies the study aimed to find the percentage of cases who retained their COVID-19 IgG antibodies 45-65 days after initially testing positive.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Repeat SARS-CoV-2 IgG antibodies at 45-65 days

All cases who initially tested positive for SARS-CoV-2 IgG antibodies would undergo a repeat test at 45-65 days

Sponsors & Collaborators

  • Tata Main Hospital

    lead OTHER

Principal Investigators

  • DR.DEB S NAG, MD · Tata Main Hospital

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-08-30
Completion
2020-08-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04605952 on ClinicalTrials.gov